0

Aurora Cannabis Inc. Continues To Get Price Targets Slashed Across The Board

Aurora Cannabis Inc. Continues To Get Price Targets Slashed Across The Board

After Aurora Cannabis Inc. (ACB.TO) (ACB) reported fourth quarter financial results that came in well below expectations, the shares plunged almost 30% on very heavy volume and traded at $0.40 on a pre-split basis.

Do not get confused, Aurora Cannabis did not trade above the $15 level in August due to the shares trading higher on positive developments. The Canadian cannabis producer was forced to conduct a 12-for-1 reverse split in order to remain listed on the NYSE. The reverse split reduced the number of shares outstanding and increased the share price. The transaction did not create value for shareholders, and we believe that our readers need to be aware of this.

In the fourth quarter, Aurora Cannabis announced a $1.8 billion asset write down and this number was not received well by the street. Following the earnings report, several broker-dealers lowered their respective price targets on Aurora Cannabis which we have highlighted below:

  1. Canaccord lowered its price target to $8.50 from $10 (CAD)
  2. CIBC lowered its price target to $10 from $21 (CAD)
  3. Piper Sandler lowered its price target to $8 from $10 (USD)
  4. Cowen and Company lowered its price target to $10 from $11 (CAD)
  5. MKM Partners lowered its price target to $9 from $18 (CAD)
  6. ATB Capital Markets lowered its price target to $10.25 from $11.30 (CAD)

The trend of broker-dealers lowering price targets on Aurora Cannabis is concerning and we will be monitoring how these banks continue to view the opportunity. During the last year, Aurora Cannabis has faced challenges with raising capital and has signed debt structured financings to raise capital. This represents a major change from 2017 and 2018 when Aurora Cannabis was able to raise hundreds-of-millions of dollars by selling equity. Going forward, we are interested in how Aurora Cannabis is able to serve the debt and make the interest payments that are associated with it.

Going forward, the name of the game for Aurora Cannabis is execution and we will monitor how the story evolves from here. The company has become highly focused on the US CBD market and this is a vertical that we are too excited about.

If you are interested in learning more about the Canadian cannabis producer, please send an email to support@technical420.com to be added to our distribution list.

Share

Share - Facebook


Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Wed, 30 Sep 2020 11:48:35 +0000

Filed in: News Tags: 

Get Updates

Share This Post

Related Posts

Leave a Reply

Submit Comment
© 9292 Michigan Medical Marijuana. All rights reserved.
Home    |    Privacy Policy